Role of infection in exacerbations of chronic obstructive pulmonary disease

Marc Miravitlles1, Antonio Anzueto

  • 1aPneumology Department, Hospital Universitari Vall d'Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain bDepartment of Medicine, Division of Pulmonary Diseases/Critical Care Medicine, The University of Texas Health Science Center at San Antonio and The South Texas Veterans Healthcare System, Audie L, Murphy Memorial Veterans Hospital Division, San Antonio, Texas, USA.

Abstract

Insights

Chronic obstructive pulmonary disease (COPD) patients with an infective phenotype show altered lung microbiomes, leading to chronic infections and more frequent bacterial exacerbations. Personalized antibiotic therapy may be required for these patients.

Area of Science:

  • Pulmonary Medicine
  • Microbiology
  • Infectious Diseases

Background:

  • Chronic obstructive pulmonary disease (COPD) is a major global health issue.
  • Infective exacerbations significantly contribute to COPD progression and mortality.
  • Understanding the role of the lung microbiome in COPD pathogenesis is crucial.

Purpose of the Study:

  • To review the latest findings on the cause, pathogenesis, and management of COPD with an infective phenotype.
  • To explore the role of the lung microbiome in COPD-related infections.
  • To discuss personalized therapeutic approaches for COPD patients with an infective phenotype.

Main Methods:

  • Literature review of recent studies on COPD, infective exacerbations, and lung microbiome.
  • Analysis of bacterial and viral roles in COPD exacerbations.
  • Investigation of microbiome alterations in COPD patients.

Main Results:

  • Over half of COPD exacerbations are infective, with bacteria isolated in 70%.
  • Viruses play a significant role, alone or with bacteria, and can precede bacterial infections in COPD.
  • COPD patients exhibit lung microbiome alterations, leading to chronic infections and increased bacterial exacerbations.

Conclusions:

  • Altered lung microbiomes in COPD patients can lead to chronic infections with potentially pathogenic microorganisms (PPMs).
  • This infective phenotype is associated with a higher frequency of bacterial exacerbations.
  • Personalized therapy, potentially including short- or long-term antibiotics, may be necessary for these patients.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.2K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.3K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.2K